IGF1R and synovial sarcoma: For instance, targeting the heparanase/heparan sulfate proteoglycan system using a supersulfated low molecular weight heparin (ssLMWH) inhibited cell colony growth and downregulated the IGF1R in synovial sarcoma preclinical models [195].